[HTML][HTML] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
A Smulever, F Pitoia - Thyroid research, 2023 - Springer
The detection of low-risk thyroid carcinoma has increased in recent decades, although
disease-specific mortality remained without changes. The high prevalence of occult …
disease-specific mortality remained without changes. The high prevalence of occult …
Recommend with caution: a meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance
Background Papillary thyroid carcinoma (PTC) is an indolent disease with favorable
outcomes. The non-surgical treatment approach known as active surveillance (AS) has been …
outcomes. The non-surgical treatment approach known as active surveillance (AS) has been …
[HTML][HTML] Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared …
A Koot, P Soares, E Robenshtok, LD Locati… - European Journal of …, 2023 - Elsevier
The incidence of differentiated thyroid cancer (DTC) has been increasing worldwide, mostly,
as an increase in the incidental detection of micro papillary thyroid carcinomas (microPTCs) …
as an increase in the incidental detection of micro papillary thyroid carcinomas (microPTCs) …
[HTML][HTML] Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and …
Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …
pathophysiology, and well-conducted prospective studies have changed the current …
Dynamic risk assessment in patients with differentiated thyroid cancer
E Abelleira, F Jerkovich - Reviews in Endocrine and Metabolic Disorders, 2024 - Springer
The current approach for patients with differentiated thyroid carcinoma should be
individualized according to the risk of recurrence, and this stratification could be used to …
individualized according to the risk of recurrence, and this stratification could be used to …
High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance
A Smulever, F Pitoia - Endocrine, 2020 - Springer
Purpose To describe the outcomes and the incidence of adverse events following active
surveillance (AS) versus immediate surgery in patients with low-risk papillary thyroid …
surveillance (AS) versus immediate surgery in patients with low-risk papillary thyroid …
Decision regret following the choice of surgery or active surveillance for small, low-risk papillary thyroid cancer: A prospective cohort study
AM Sawka, S Ghai, L Rotstein, JC Irish, JD Pasternak… - Thyroid, 2024 - liebertpub.com
Background: It is important to understand cancer survivors' perceptions about their treatment
decisions and quality of life. Methods: We performed a prospective observational cohort …
decisions and quality of life. Methods: We performed a prospective observational cohort …
[HTML][HTML] Assessing mPTC progression during active surveillance: volume or diameter increase?
MC Campopiano, A Matrone, T Rago, M Scutari… - Journal of Clinical …, 2021 - mdpi.com
Active surveillance (AS) is considered an alternative to immediate surgery in micropapillary
thyroid carcinoma (mPTC). However, the definition of clinical mPTC progression during AS …
thyroid carcinoma (mPTC). However, the definition of clinical mPTC progression during AS …
[HTML][HTML] Decision-making in surgery or active surveillance for low risk papillary thyroid cancer during the COVID-19 pandemic
AM Sawka, S Ghai, O Ihekire, JM Jones, A Gafni… - Cancers, 2021 - mdpi.com
Simple Summary In March of 2020, the World Health Organization declared a COVID-19
pandemic, which had dramatic implications for thyroid cancer clinical care and research …
pandemic, which had dramatic implications for thyroid cancer clinical care and research …
[HTML][HTML] Web-based ultrasonic nomogram predicts preoperative central lymph node metastasis of cN0 papillary thyroid microcarcinoma
C Huang, S Cong, S Shang, M Wang… - Frontiers in …, 2021 - frontiersin.org
Background Many clinicians are facing the dilemma about whether they should apply the
active surveillance (AS) strategy for managing Clinically Node-negative (cN0) PTMC …
active surveillance (AS) strategy for managing Clinically Node-negative (cN0) PTMC …